Shares of Bristol-Myers Squibb Have Risen Above Previous 52-Week HighFinancial News Network OnlineThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant…
Bristol-Myers Squibb (BMY) Crosses Pivot Point Resistance at $34.57Financial News Network OnlineThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant r…
Bristol-Myers Squibb (BMY) Breaks Through Resistance at $34.45Financial News Network OnlineThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant reject…
Marlboro company becomes focus of stem cell therapeuticsWorcester TelegramCorporate researchers are using adult stem cells from blood, marrow, placenta and other sources to develop treatments for heart disease, Lou Gehrig's disease, peripheral arte…
Uterine transplants: a new frontier in scienceIndianapolis StarHow might transplant rejection drugs affect a fetus? The hunger for answers is strong enough that an Indiana University gynecologist convened a conference Dec. 5 at which two dozen people, …
Top Losers in After-hours Today, Dec-16Beacon Equity Research… Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-threatening disease states, including hematologic and neurologic diseases, transplant r…
National network formed to accelerate discoveries about the human immune systemHealthCanal.comFrom developing vaccines to discovering new therapies to treat autoimmune diseases and transplant rejection, from improving food and water safety to preparedn…
J&J and Pfizer Lead PNC Financial's Heaviest Healthcare Share Holdings in Q3Wall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ tran…
BlackRock, Inc.'s Heaviest Healthcare Share Positions: JNJ, VRX, PFEWall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejec…
Stocks Achieving 52-Week Highs as S&P 500 Closes at 1215Wall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psy…